Evoke Pharma Inc.

NASDAQ: EVOK · Real-Time Price · USD
5.10
-0.04 (-0.78%)
At close: Aug 15, 2025, 3:31 PM

Evoke Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
13.6M 4.74M 9.84M 9.14M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
126.92K 241.64K -129.07K -12.43K
Receivables
2.42M 673.07K 624.83K 295.19K
Inventory
445.08K 481.84K 289.38K 185.53K
Other Current Assets
43.9K 47.53K 11.55K 11.55K
Total Current Assets
17.24M 6.83M 11.72M 10.56M
Property-Plant & Equipment
154.18K n/a 129.07K 12.43K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
281.11K 241.64K 129.07K 12.43K
Total Assets
17.52M 7.07M 11.85M 10.57M
Account Payables
2.34M 1.71M 868.31K 874.03K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
5M 5M 129.07K 12.43K
Other Current Liabilities
2.11M 1.32M 528.08K 506.89K
Total Current Liabilities
10.38M 9.65M 1.65M 1.41M
Long-Term Debt
n/a 5M 5M 5M
Other Long-Term Liabilities
n/a 1.61M 1.11M 612.29K
Total Long-Term Liabilities
100.96K 6.61M 6.11M 5.61M
Total Liabilities
10.48M 9.65M 7.77M 7.02M
Total Debt
5.16M 5M 5.13M 5.01M
Common Stock
149.00 334.00 334.00 3.27K
Retained Earnings
-128.79M -123.44M -115.65M -107.42M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
7,038B -2.58M 4.08M 3.56M
Total Investments
13,596.6B n/a n/a n/a